Topical Product

Market Potential

  • As Baby Boomers age, aches and pains are affecting their daily activities (tennis elbow, hand/knuckle pain, ankles)
  • Mild to moderate osteoarthritis affects more than 25 million people in the U.S.
  • Local treatment reduces many of the side effects associated with NSAIDs – GI, cardiovascular
  • A cream formulation easily treats elbows, knuckles, and ankles. It rubs in completely without being messy
  • Using post-approval studies, this product has the potential to be over-the-counter
wrist bones injury

Competition

  • The most common treatment for osteoarthritis are oral, generally NSAIDs such as ibuprofen (Advil®, Motrin®) or naproxen (Aleve®)
  • Another available treatment is a 1% diclofenac gel formulation (Voltaren® Gel). It is approved for osteoarthritis. (2015 revenue ~ $190 million)
  • VIMOVO® is an FDA-approved prescription combination medication that relieves arthritis pain and offers gastroprotection to help reduce the risk of stomach problems related to naproxen use. Horizon Pharma has U.S. rights. Cost for 60 tablets ~ $2074
Colorful pills and syringe over dark background